Drug data last refreshed 2h ago · AI intelligence enriched 5h ago
OXYGEN, USP is a pharmaceutical-grade oxygen gas administered via inhalation to treat hypoxemia and respiratory conditions. As an essential therapeutic gas, it restores adequate oxygen saturation in patients with compromised pulmonary or cardiovascular function. Oxygen acts by increasing arterial oxygen tension and improving tissue oxygenation.
Peak lifecycle status indicates a stable, mature product with established market presence and a small, focused commercial team.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Pulmonary Hypertension and Oxygen Saturation Targeting in Preterm Infants
Safety Study of Intravenous Hydrogen-Oxygen Ultrafine Bubbles in Adults
MolecuLight All-in-One Oxygenation Clinical Utility
Endoscopic COlorectal Mucosal Evaluation of Oxygen Tension
Impact of Intraoperative Oxygenation Practices on Patient Outcomes
Worked on OXYGEN, USP at Universal Cells? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Career opportunities on OXYGEN, USP are concentrated in design and creative functions within Universal Cells' design studio, suggesting focus on packaging, user interfaces, delivery device design, or marketing materials rather than commercial or clinical roles. This represents a specialized, niche opportunity for design professionals seeking involvement in a foundational healthcare product.
4 open roles linked to this drug